Eikon Therapeutics (NAS: EIKN)

Millbrae, CA · Founded 2019 · Publicly Held

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet… Eikon Therapeutics (NAS: EIKN) is based in Millbrae, CA and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $972 million (Feb 2026). It has raised $1.5 billion.

Last price · $/share

—

Implied valuation

$971.7M

Total raised

$1.5B

Last round

—

How much has Eikon Therapeutics (NAS: EIKN) raised?

$1.5Bacross 0 recorded rounds

Free account

More of Eikon Therapeutics (NAS: EIKN) with a free account

·The complete investor list: 22 names
·Watch Eikon Therapeutics (NAS: EIKN): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Eikon Therapeutics (NAS: EIKN) investors

22 investors are on record for Eikon Therapeutics (NAS: EIKN), including General Catalyst, Lux Capital, Alexandria Venture Investments and StepStone Group. By type, the record holds 7 venture capital firms and 1 family office.

For fundraisers

Raising for a company like Eikon Therapeutics (NAS: EIKN)?

22 investors have backed Eikon Therapeutics (NAS: EIKN).

See all 22 investors →

Frequently asked about Eikon Therapeutics (NAS: EIKN)

How much has Eikon Therapeutics (NAS: EIKN) raised?: Eikon Therapeutics (NAS: EIKN) has raised $1.5B in total across 0 recorded funding rounds.